Display Settings:

Format

Send to:

Choose Destination
    J Clin Invest. 2011 Dec;121(12):4627-30. doi: 10.1172/JCI61126. Epub 2011 Nov 21.

    Another VCP interactor: NF is enough.

    Source

    Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri 63110, USA. weihlc@neuro.wustl.edu

    Abstract

    Inclusion body myopathy with Paget disease of the bone and frontotemporal dementia (IBMPFD) is a multisystem degenerative disorder caused by mutations in the valosin-containing protein (VCP) gene. How missense mutations in this abundant, ubiquitously expressed, multifunctional protein lead to the degeneration of disparate tissues is unclear. VCP participates in diverse cellular functions by associating with an expanding collection of substrates and cofactors that dictate its functionality. In this issue of the JCI, Wang and colleagues have further expanded the VCP interactome by identifying neurofibromin-1 (NF1) as a novel VCP interactor in the CNS. IBMPFD-associated mutations disrupt binding of VCP to NF1, resulting in reduced synaptogenesis. Thus, aberrant interactions between VCP and NF1 may explain the dementia phenotype and cognitive delay observed in patients with IBMPFD and neurofibromatosis type 1.

    PMID:
    22105166
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3226341
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1

      Supplemental Content

      Icon for Journal of Clinical Investigation Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk